Advisory Committee on Immunization Practices (ACIP), 30044 [2010-12818]
Download as PDF
<![CDATA[
jlentini on DSKJ8SOYB1PROD with NOTICES
30044
Federal Register / Vol. 75, No. 103 / Friday, May 28, 2010 / Notices
Retirement; Kathy Hughes, Vice
Chairwoman, Oneida Nation; Gail Hunt,
President and Chief Executive Officer,
National Alliance for Caregiving;
Warren Jones, M.D., F.A.A.F.P.,
Executive Director, Mississippi Institute
for Improvement of Geographic
Minority Health; Sandy Markwood,
Chief Executive Officer, National
Association of Area Agencies on Aging;
David W. Roberts, M.P.A., Vice
President, Government Relations,
Healthcare Information and
Management System Society; Julie
Boden Schmidt, M.S., Associate Vice
President, Training and Technical
Assistance, National Association of
Community Health Centers; Rebecca P.
Snead, Chief Executive Officer and
Executive Vice President, National
Alliance of State Pharmacy Associations
and APME Chair; Donna Yee, PhD,
Chief Executive Officer, Asian
Community Center of Sacramento
Valley; Deeanna Jang, Policy Director,
Asian and Pacific Islander American
Health Forum; Andrew Kramer, M.D.,
Professor of Medicine, Division of
Health Care Policy and Research,
University of Colorado, Denver; John
Lui, PhD, M.B.A., Executive Director,
Stout Vocational Rehabilitation
Institute.
The agenda for the June 22, 2010
meeting will include the following:
• Recap of the previous (March 31,
2010) meeting.
• Subgroup Committee Work
Summary.
• Medicare Outreach and Education
Strategies.
• Public Comment.
• Listening Session with CMS
Leadership.
• Next Steps.
Individuals or organizations that wish
to make a 5-minute oral presentation on
an agenda topic should submit a written
copy of the oral presentation to the DFO
at the address listed in the ADDRESSES
section of this notice by the date listed
in the DATES section of this notice. The
number of oral presentations may be
limited by the time available.
Individuals not wishing to make a
presentation may submit written
comments to the DFO at the address
listed in the ADDRESSES section of this
notice by the date listed in the DATES
section of this notice.
Individuals requiring sign language
interpretation or other special
accommodations should contact the
DFO at the address listed in the
ADDRESSES section of this notice by the
date listed in the DATES section of this
notice.
Authority: Sec. 222 of the Public Health
Service Act (42 U.S.C. 217a) and sec. 10(a)
VerDate Mar<15>2010
17:43 May 27, 2010
Jkt 220001
of Pub. L. 92–463 (5 U.S.C. App. 2, sec. 10(a)
and 41 CFR 102–3).
both CDC and the Agency for Toxic
Substance and Disease Registry.
(Catalog of Federal Domestic Assistance
Program No. 93.733, Medicare—Hospital
Insurance Program; and Program No. 93.774,
Medicare—Supplementary Medical
Insurance Program)
Dated: May 20, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
Dated: May 13, 2010.
Marilyn Tavenner,
Acting Administrator, Centers for Medicare
& Medicaid Services.
[FR Doc. 2010–12818 Filed 5–27–10; 8:45 am]
[FR Doc. 2010–12457 Filed 5–27–10; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Immunization
Practices (ACIP)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee:
Times and Dates:
8 a.m.–6 p.m., June 23, 2010.
8 a.m.–3 p.m., June 24, 2010.
Place: CDC, Tom Harkin Global
Communications Center, 1600 Clifton Road,
NE., Building 19, Kent ‘‘Oz’’ Nelson
Auditorium, Atlanta, Georgia 30333.
Status: Open to the public, limited only by
the space available.
Purpose: The committee is charged with
advising the Director, CDC, on the
appropriate uses of immunizing agents. In
addition, under 42 U.S.C. 1396s, the
committee is mandated to establish and
periodically review and, as appropriate,
revise the list of vaccines for administration
to vaccine-eligible children through the
Vaccines for Children (VFC) program, along
with schedules regarding the appropriate
periodicity, dosage, and contraindications
applicable to the vaccines.
Matters To Be Discussed: The agenda will
include discussions on: Evidence based
recommendations; human papillomavirus
(HPV) vaccines; 13-valent pneumococcal
conjugate vaccine; meningococcal vaccine;
hepatitis vaccines; a vaccine supply update;
respiratory syncytial virus
immunoprophylaxis vaccine; rotavirus
vaccines; pertussis vaccine; and influenza
vaccines. Agenda items are subject to change
as priorities dictate.
Contact Person for More Information:
Antonette Hill, Immunization Services
Division, National Center for Immunization
and Respiratory Diseases, CDC, 1600 Clifton
Road, NE., (E–05), Atlanta, Georgia 30333,
telephone 404/639–8836, fax 404/639–8905.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
BILLING CODE 4160–18–P
Centers for Disease Control and
Prevention
Partnerships To Advance the National
Occupational Research Agenda
(NORA)
AGENCY: The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice of public meeting.
SUMMARY: The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC)
announces the following public
meeting: ‘‘Partnerships to Advance the
National Occupational Research Agenda
(NORA)’’.
Public Meeting Time and Date:
10 a.m.–4 p.m. EDT, June 16, 2010.
Place: Patriots Plaza, 395 E. Street,
SW., Conference Room 9000,
Washington, DC 20201.
Purpose of Meeting: The National
Occupational Research Agenda (NORA)
has been structured to engage partners
with each other and/or with NIOSH to
advance NORA priorities. The NORA
Liaison Committee continues to be an
opportunity for representatives from
organizations with national scope to
learn about NORA progress and to
suggest possible partnerships based on
their organization’s mission and
contacts. This opportunity is now
structured as a public meeting via the
internet to attract participation by a
larger number of organizations and to
further enhance the success of NORA.
Some of the types of organizations of
national scope that are especially
encouraged to participate are employers,
unions, trade associations, labor
associations, professional associations,
and foundations. Others are welcome.
This meeting will include updates
from NIOSH leadership on NORA as
well as updates from approximately half
of the NORA Sector Councils on their
progress, priorities, and implementation
E:\FR\FM\28MYN1.SGM
28MYN1
]]>Agencies
[Federal Register Volume 75, Number 103 (Friday, May 28, 2010)]
[Notices]
[Page 30044]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-12818]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Immunization Practices (ACIP)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
committee:
Times and Dates:
8 a.m.-6 p.m., June 23, 2010.
8 a.m.-3 p.m., June 24, 2010.
Place: CDC, Tom Harkin Global Communications Center, 1600
Clifton Road, NE., Building 19, Kent ``Oz'' Nelson Auditorium,
Atlanta, Georgia 30333.
Status: Open to the public, limited only by the space available.
Purpose: The committee is charged with advising the Director,
CDC, on the appropriate uses of immunizing agents. In addition,
under 42 U.S.C. 1396s, the committee is mandated to establish and
periodically review and, as appropriate, revise the list of vaccines
for administration to vaccine-eligible children through the Vaccines
for Children (VFC) program, along with schedules regarding the
appropriate periodicity, dosage, and contraindications applicable to
the vaccines.
Matters To Be Discussed: The agenda will include discussions on:
Evidence based recommendations; human papillomavirus (HPV) vaccines;
13-valent pneumococcal conjugate vaccine; meningococcal vaccine;
hepatitis vaccines; a vaccine supply update; respiratory syncytial
virus immunoprophylaxis vaccine; rotavirus vaccines; pertussis
vaccine; and influenza vaccines. Agenda items are subject to change
as priorities dictate.
Contact Person for More Information: Antonette Hill,
Immunization Services Division, National Center for Immunization and
Respiratory Diseases, CDC, 1600 Clifton Road, NE., (E-05), Atlanta,
Georgia 30333, telephone 404/639-8836, fax 404/639-8905.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities for both CDC and the Agency for Toxic Substance and
Disease Registry.
Dated: May 20, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2010-12818 Filed 5-27-10; 8:45 am]
BILLING CODE 4160-18-P
